Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  2. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  3. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  4. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  5. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  6. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  7. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  8. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  9. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  10. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  11. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  12. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  13. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  14. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  15. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  16. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  17. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  18. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  19. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  20. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  21. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  22. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  23. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  24. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  25. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  26. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  27. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  28. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  29. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  30. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  31. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  32. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  33. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  34. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  35. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  36. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  37. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  38. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  39. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  40. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  41. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  42. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  43. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  44. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  45. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  46. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  47. Poli V, et al. 2021. iScience. 24:103256. PubMed
  48. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  49. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  50. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  51. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  52. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  53. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  54. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  55. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  56. Chen S, et al. 2022. Cancer Discov. :. PubMed
  57. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  58. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  59. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  60. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  61. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  62. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  63. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  64. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  65. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  66. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  67. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  68. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  69. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  70. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  71. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  72. Li B, et al. 2022. iScience. 25:103772. PubMed
  73. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  74. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  75. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  76. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  77. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  78. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  79. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  80. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  81. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  82. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  83. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  84. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  85. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  86. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  87. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  88. Kasper M, et al. 2021. Elife. 10:. PubMed
  89. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  90. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  91. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  92. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  93. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  94. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  95. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  96. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  97. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  98. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  99. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  100. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  101. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  102. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  103. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  104. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  105. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  106. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  107. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  108. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  109. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  110. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  111. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  112. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  113. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  114. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  115. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  116. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  117. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  118. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  119. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  120. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  121. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  122. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  123. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  124. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  125. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  126. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  127. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  128. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  129. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  130. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  131. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  132. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  133. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  134. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  135. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  136. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  137. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  138. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  139. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  140. Gao H, et al. 2021. Cells. 10:. PubMed
  141. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  142. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  143. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  144. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  145. Köchl R, et al. 2020. Elife. 9:00. PubMed
  146. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  147. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  148. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  149. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  150. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  151. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  152. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  153. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  154. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  155. Dong S, et al. 2021. Nature. 591:117. PubMed
  156. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  157. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  158. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  159. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  160. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  161. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  162. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  163. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  164. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  165. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  166. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  167. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  168. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  169. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  170. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  171. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  172. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  173. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  174. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  175. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  176. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  177. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  178. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  179. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  180. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  181. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  182. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  183. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  184. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  185. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  186. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  187. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  188. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  189. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  190. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  191. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  192. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  193. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  194. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  195. Cho K, et al. 2021. iScience. 24:103117. PubMed
  196. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  197. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  198. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  199. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  200. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  201. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  202. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  203. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  204. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  205. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  206. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  207. Dong L, et al. 2022. Cells. 11:. PubMed
  208. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  209. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  210. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  211. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  212. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  213. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  214. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  215. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  216. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  217. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  218. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  219. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  220. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  221. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  222. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  223. Liu P, et al. 2022. iScience. 25:103867. PubMed
  224. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  225. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  226. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  227. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  228. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  229. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  230. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  231. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  232. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  233. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  234. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  235. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  236. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  237. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  238. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  239. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  240. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  241. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  242. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  243. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  244. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  245. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  246. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  247. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  248. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  249. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  250. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  251. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  252. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  253. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  254. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  255. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  256. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  257. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  258. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  259. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  260. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  261. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  262. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  263. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  264. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  265. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  266. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  267. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  268. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  269. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  270. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  271. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  272. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  273. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  274. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  275. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  276. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  277. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  278. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  279. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  280. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  281. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  282. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  283. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  284. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  285. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  286. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  287. Tang S, et al. 2022. Virol J. 19:32. PubMed
  288. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  289. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  290. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  291. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  292. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  293. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  294. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  295. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  296. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  297. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  298. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  299. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  300. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  301. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  302. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  303. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  304. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  305. Wang X, et al. 2022. Elife. 11:. PubMed
  306. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  307. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  308. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  309. Liu SS, et al. 2021. Immunity. :. PubMed
  310. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  311. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  312. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  313. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  314. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  315. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  316. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  317. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  318. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  319. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  320. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  321. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  322. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  323. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  324. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  325. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  326. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  327. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  328. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  329. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  330. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  331. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  332. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  333. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  334. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  335. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  336. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  337. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  338. Wang S, et al. 2022. Blood. 140:171. PubMed
  339. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  340. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  341. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  342. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  343. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  344. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  345. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  346. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  347. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  348. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  349. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  350. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  351. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse/human CD11b

  • Biotin anti-mouse/human CD11b

  • FITC anti-mouse/human CD11b

  • PE anti-mouse/human CD11b

  • PE/Cyanine5 anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b

  • PE/Cyanine7 anti-mouse/human CD11b

  • Alexa Fluor® 488 anti-mouse/human CD11b

  • Alexa Fluor® 647 anti-mouse/human CD11b

  • Alexa Fluor® 700 anti-mouse/human CD11b

  • Pacific Blue™ anti-mouse/human CD11b

  • APC/Cyanine7 anti-mouse/human CD11b

  • PerCP/Cyanine5.5 anti-mouse/human CD11b

  • PerCP anti-mouse/human CD11b

  • Brilliant Violet 421™ anti-mouse/human CD11b

  • Brilliant Violet 570™ anti-mouse/human CD11b

  • Brilliant Violet 605™ anti-mouse/human CD11b

  • Brilliant Violet 650™ anti-mouse/human CD11b

  • Brilliant Violet 711™ anti-mouse/human CD11b

  • Brilliant Violet 785™ anti-mouse/human CD11b

  • Brilliant Violet 510™ anti-mouse/human CD11b

  • Ultra-LEAF™ Purified anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse/human CD11b

  • PE/Dazzle™ 594 anti-mouse/human CD11b

  • APC/Fire™ 750 anti-mouse/human CD11b

  • TotalSeq™-A0014 anti-mouse/human CD11b

  • Brilliant Violet 750™ anti-mouse/human CD11b

  • TotalSeq™-B0014 anti-mouse/human CD11b

  • TotalSeq™-C0014 anti-mouse/human CD11b

  • Spark NIR™ 685 anti-mouse/human CD11b

  • PE/Fire™ 640 anti-mouse/human CD11b

  • Spark YG™ 593 anti-mouse/human CD11b

  • Spark YG™ 570 anti-mouse/human CD11b

  • PE/Fire™ 810 anti-mouse/human CD11b

  • APC/Fire™ 810 anti-mouse/human CD11b Antibody

  • Spark Blue™ 550 anti-mouse/human CD11b

  • Spark UV™ 387 anti-mouse/human CD11b

  • PerCP/Fire™ 806 anti-mouse/human CD11b
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account